Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Frontiers in Psychiatry|September 2, 2025
Childhood trauma and relationship with the parents: associations with lipids, glucose, and prolactin levels during antipsychotic treatment in patients with first-episode psychosisMarianne Laffely, Claire Grosu, Nermine Laaboub, et al.Schizophrenia Bulletin|February 26, 2023
Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort StudyMarianna Piras, Jihane Chahma, Setareh Ranjbar, et al.Schizophrenia Bulletin|September 26, 2022
Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort StudyMarianna Piras, Setareh Ranjbar, Nermine Laaboub, et al.Clinical Pharmacokinetics|September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic AnalysesAnaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.Translational Psychiatry|August 5, 2022
CYP2C19 expression modulates affective functioning and hippocampal subiculum volume-a large single-center community-dwelling cohort studyClaire Grosu, Olga Trofimova, Mehdi Gholam-Rezaee, et al.Revue Medicale Suisse|September 27, 2018
[MRI of medial-temporal atrophy as a biomarker for Alzheimer's disease]Aliaa Ahmed Ibnidris Elsiddig, Claire Grosu, Cecilia Ferrer Soler, et al.Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.The Journal of Clinical Psychiatry|March 27, 2024
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort StudyClaire Grosu, William Hatoum, Marianna Piras, et al.Frontiers in Psychiatry|February 28, 2024
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patientsNermine Laaboub, Isabella Locatelli, Claire Grosu, et al.Clinical Epigenetics|February 28, 2024
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational studyCéline Dubath, Eleonora Porcu, Aurélie Delacrétaz, et al.Pageof 2